Uterine Fibroid Treatment Devices Market is estimated to be US$ 15.6 billion by 2032; Growing Prevalence of Uterine Fibroid Tumors to Fuel Market Growth - By PMI

Prophecy Market Insights latest research report on the Uterine Fibroid Treatment Devices Market provides a comprehensive analysis of the current market scenario, growth opportunities, challenges, and emerging trends. The report offers insights into the market's size and share, key market players, distribution channels, and consumer preferences. It also examines the impact of the COVID-19 pandemic on the market and provides a detailed analysis of the competitive landscape, including strategic alliances, mergers, and acquisitions.

| Quelle: PMI PMI

Covina, April 25, 2023 (GLOBE NEWSWIRE) -- Uterine fibroids are non-cancerous tumors that develop in the woman's uterus and can vary in shape and size of the person. Further, a number of therapies and treatments, such as drugs and surgeries are being used to treat the onset symptoms of uterine fibroids. As per the National Institute of Health, the study found that most American women may develop uterine fibroids at some point in their lives. Around 70% of whites and 80% of African women developed fibroids by older people of 50 years. Thus, the data represent the high incidence rate of uterine fibroids, and the demand for the proper treatment will be huge in the coming years which in turn is expected to fuel the demand for Uterine Fibroid Treatment Devices Market growth over the forecast period.

The report “Uterine Fibroid Treatment Devices Market, By Technology Type (Surgical Technique (Myomectomy and Hysterectomy), Laparoscopic techniques (Myolysis and Laparoscopic Myomectomy) Ablation Techniques (Cryoablation, Microwave Ablation, and Ultrasound Ablation (MRI-guided Focused Ultrasound (MRgFUS) and High Intensity Focused Ultrasound (HIFU)), Other Ablation Techniques) Embolization Techniques) By Mode of Treatment (Minimally Invasive Treatment, Invasive Treatment, and Non-Invasive Treatment), By End-User (Clinics, Hospitals, and Ambulatory Surgical Center), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

 Key Highlights:

  • In November 2018, Acessa Health launched new “Acessa ProVu System” with FDA (Food and Drug Administration” for treating uterine fibroid diseases with minimally invasive laparoscopic and fully radiofrequency ablation.

Analyst View:

Robust growth in healthcare infrastructure in emerging economies and favorable reimbursement policies will push patients to undergo treatment of uterine fibroids. Medicare & Medicaid – a national social insurance program in the U.S. which helps to cover payments and reimbursement policies in hospitals and ambulatory surgical centers are likely to propel the overall growth of the global uterine fibroid treatment device market during the forecast period.


Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Uterine Fibroid Treatment Devices Market, By Technology Type (Surgical Technique (Myomectomy and Hysterectomy), Laparoscopic techniques (Myolysis and Laparoscopic Myomectomy) Ablation Techniques (Cryoablation, Microwave Ablation, and Ultrasound Ablation (MRI-guided Focused Ultrasound (MRgFUS) and High Intensity Focused Ultrasound (HIFU)), Other Ablation Techniques) Embolization Techniques) By Mode of Treatment (Minimally Invasive Treatment, Invasive Treatment, and Non-Invasive Treatment), By End-User (Clinics, Hospitals, and Ambulatory Surgical Center), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

Request Free Sample Copy:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/140

Scope of the Report:

  1. Uterine Fibroid Treatment Devices Market, By Technology Type
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Surgical Technique
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Laparoscopic Techniques
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Ablation Techniques
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Embolization Techniques
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
  2. Uterine Fibroid Treatment Devices Market, By Mode of Treatment, 2022 – 2032, (US$ Bn)
    • Overview                                      
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Minimally Invasive Treatment
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Invasive Treatment
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Non-invasive Treatment
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
  3. Uterine Fibroid Treatment Devices Market, By End-Users, 2022 – 2032, (US$ Bn)
    • Overview                                      
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Clinics
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Ambulatory Surgical Center
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032

Key Market Insights from the report:
Uterine Fibroid Treatment Devices Market accounted for US$ 6.0 billion in 2022 and is estimated to be US$ 15.6 billion by 2032 and is anticipated to register a CAGR of 9.4%. The Uterine Fibroid Treatment Devices Market is segmented based on Technology Type, Mode of Treatment, End-Users and Region.

  • Based on Technology Type, Uterine Fibroid Treatment Devices Market is segmented into Surgical Technique, Laparoscopic Techniques, Ablation Techniques and Embolization Techniques.
  • Based on Mode of Treatment, Uterine Fibroid Treatment Devices Market is segmented into Minimally Invasive Treatment, Invasive Treatment and Non-Invasive Treatment.
  • Based on End-Users, Uterine Fibroid Treatment Devices Market is segmented into Clinics, Hospitals and Ambulatory Surgical Center.
  • By Region, the Uterine Fibroid Treatment Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Free PDF Download Now:
https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/140

Competitive Landscape & their strategies of Uterine Fibroid Treatment Devices Market:

  • Boston Scientific Corporation
  • CONMED Corporation
  • PENTAX Medical
  • Advanced Surgical Concepts
  • PLLC
  • Ethicon
  • Hologic
  • Medtronic
  • CooperSurgical
  • Olympus Corporation
  • Stryker Corporation

Regional scope:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Other Related Reports:

Dental Burs Market: By Material (Diamond Burs, Carbide Burs, Stainless Steel Burs), By Application (Orthodontics, Oral Surgery, Cavity Preparation, Implantology, and Others), By End-Users (Dental Clinics, Hospitals, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

Gynecological Devices Market : By Product (Gynecological Endoscopy Devices, Endometrial Ablation Devices, Fluid Management Systems, Female Sterilization & Contraceptive Devices, Diagnostic Imaging System, Handheld Instruments), By End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgery Centers (ASCs)), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

Blood Testing Market :  By Test Type (Complete Blood Test, Kidney Test-Renal Profile, Cholesterol Test-Lipid Profile Test, Blood Glucose Test, Antibodies Test-Rheumatoid factor, Urine Test, Infectious Disease Screening, Cancer Test, Heart Test), By Product ( Instruments, Reagents & Kits, Software), Disease (Anemia, Infection, Leukemia), By Method ( Manual Blood Testing, Automated Blood Testing), , By End Use (Hospitals, Pathology Labs, Blood Banks, Diagnostic Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

 

            








        

            

                

                    
Tags

                            
                                fibroid growth rate
                            
                            
                                uterine fibroid treatment
                            
                            
                                fibroid growth
                            
                            
                                treat uterine fibroids
                            
                            
                                treating uterine fibroids
                            
                            
                                PENTAX Medical
                            

                



        


    

        
Weiterführende Links

        
    



    

        

        
Kontaktdaten